These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 32964952)

  • 1. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.
    Labetoulle M; Benitez-Del-Castillo JM; Barabino S; Herrero Vanrell R; Daull P; Garrigue JS; Rolando M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
    Daull P; Amrane M; Ismail D; Georgiev G; Cwiklik L; Baudouin C; Leonardi A; Garhofer G; Garrigue JS
    J Ocul Pharmacol Ther; 2020; 36(6):355-365. PubMed ID: 32493105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial.
    Balal S; Udoh A; Pappas Y; Cook E; Barton G; Hassan A; Hayden K; Bourne RRA; Ahmad S; Pardhan S; Harrison M; Sharma B; Wasil M; Sharma A
    BMJ Open; 2018 Oct; 8(10):e026770. PubMed ID: 30385451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial.
    Kallab M; Szegedi S; Hommer N; Stegmann H; Kaya S; Werkmeister RM; Schmidl D; Schmetterer L; Garhöfer G
    Adv Ther; 2020 Jan; 37(1):329-341. PubMed ID: 31741283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
    Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
    Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for 24-hour management of dry eye disease: A review.
    Guillon M; Shah S
    Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem.
    Montero-Iruzubieta J; Sanchez Hernandez MC; Dávila I; Leceta A
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):439-445. PubMed ID: 38095493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology, diagnosis, and treatment of dry eye disease.
    Messmer EM
    Dtsch Arztebl Int; 2015 Jan; 112(5):71-81; quiz 82. PubMed ID: 25686388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief.
    Shahraki T; Baradaran-Rafii A; Ayyala R; Arabi A; Jarstad J; Memar F
    Int Ophthalmol; 2024 Feb; 44(1):49. PubMed ID: 38337030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
    Srinivasan S; Williams R
    Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
    Srinivasan S; Garofalo R; Williams R
    Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Nano-ophthalmology in Treating Dry Eye Disease.
    Natesan S; Boddu SHS; Krishnaswami V; Shahwan M
    Pharm Nanotechnol; 2020; 8(4):258-289. PubMed ID: 32600244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis.
    Jongkhajornpong P; Anothaisintawee T; Lekhanont K; Numthavaj P; McKay G; Attia J; Thakkinstian A
    Cornea; 2022 Sep; 41(9):1137-1149. PubMed ID: 34924549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.